D-0377-2021 Class II Terminated
FDA drug recall D-0377-2021 was initiated by Teva Pharmaceuticals USA on Apr 26, 2021 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Jun 4, 2024). Affected quantity: 3,138/25 single use vials per tray.
Recall details
- Product Type
- Drugs
- Report Date
- May 26, 2021
- Initiation Date
- Apr 26, 2021
- Termination Date
- Jun 4, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,138/25 single use vials per tray
Product description
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 2 mL Single-Use Vial, Rx Only, TEVA Parenteral Medicines, Inc. Irvine, CA 92618 NDC 0703-4502-04
Reason for recall
Lack of Assurance of Sterility
Distribution pattern
Product was distributed nationwide.
Code information
Lot # 31325459B, exp. date 08/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0377-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026